Migration of T-cell subsets in multiple sclerosis and the effect of interferon-β1a

Acta Neurologica Scandinavica

Volumn 116, Issue 3, 2007, Pages 164-168

  Dressel, A ^a   Mirowska Guzel, D ^b,c   Gerlach, C ^a   Weber, F ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

CD4+ T cells; CD8+ T cells; Interferon ; Lymphocytes; Migration; Multiple sclerosis; T cells

Indexed keywords

BETA1A INTERFERON; GELATINASE B;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; LYMPHOCYTE MIGRATION; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; FEMALE; HUMANS; INTERFERON-BETA; LONGITUDINAL STUDIES; MALE; MATRIX METALLOPROTEINASE 9; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 34547860412     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00829.x     Document Type: Article

References (22)

1. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002 125 : 2202 12.
2. Tsuchida T, Parker KC, Turner RV, McFarland HF, Coligan JE, Biddison WE. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc Natl Acad Sci USA 1994 91 : 10859 63.
3. Dressel A, Chin JL, Sette A, Gausling R, Hollsberg P, Hafler DA. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands. J Immunol 1997 159 : 4943 51.
4. Ram M, Sherer Y, Shoenfeld Y. Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol 2006 26 : 299 307.
5. Polman CH, O'Connor PW, Havrdova E et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006 354 : 899 910.
6. Rudick RA, Stuart WH, Calabresi PA et al. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 2006 354 : 911 23.
7. Yong VW, Chabot S, Stüve O, Williams G. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 1998 51 : 682 9.
8. Kraus J, Ling AK, Hamm S, Voigt K, Oschmann P, Engelhardt B. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Ann Neurol 2004 56 : 192 205.
9. Stüve O, Dooley NP, Uhm JH et al. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 1996 40 : 853 63.
10. Johnatty R, Taub D, Reeder S et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997 158 : 2327 33.
11. Uhm JH, Dooley NP, Stüve O et al. Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy. Ann Neurol 1999 46 : 319 24.
12. Prat A, Al-Asmi A, Duquette P, Antel JP. Lymphocyte migration and multiple sclerosis: relation with disease course and therapy. Ann Neurol 1999 46 : 253 6.
13. Gelati M, Corsini E, Dufour A et al. Transmigration of PBMNCs from beta-IFN-1b-treated MS patients: a one-year longitudinal study. Autoimmunity 2001 33 : 275 83.
14. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13 : 227 31.
15. Maliszewska M, Mäder M, Scholl U et al. Development of an ultrasensitive enzyme immunoassay for the determination of matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid. J Neuroimmunol 2001 116 : 233 7.
16. Leppert D, Waubant E, Burk MR, Oksenberg JR, Hauser SL. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol 1996 40 : 846 52.
17. Stüve O, Marra CM, Jerome KR et al. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol 2006 59 : 743 7.
18. Stüve O, Marra CM, Bar-Or A et al. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 2006 63 : 1383 7.
19. Babbe H, Roers A, Waisman A et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000 192 : 393 404.
20. Jacobsen M, Cepok S, Quak E et al. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002 125 : 538 50.
21. Crawford MP, Yan SX, Ortega SB et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004 103 : 4222 31.
22. Dressel A, Vogelgesang A, Brinkmeier H, Mäder M, Weber F. Glatiramer acetate-specific human CD8+ T cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment. J Neuroimmunol 2006 181 : 133 40.